InterFase® is a unique enzyme formulation that is especially designed to disrupt the biofilm matrix that embeds gastrointestinal organisms. Enzymes in InterFase® are selected for their ability to lyse the extracellular polymers commonly found in biofilm as well as degrade bacterial and yeast cell wall structures. The enzyme blend in InterFase® was developed using in vitro testing of antibiofilm activity and was found to have significant antibiofilm activity resulting in meaningful degradation of undesirable biofilm communities. InterFase® is intended for use in conjunction with efforts to support normal gastrointestinal function and microbiota. As an adjunct, it is best combined with use of a high-strength, broad-spectrum, multispecies probiotic formulation and a prebiotic to encourage the formation of healthy intestinal microbial biofilm communities.
